Enter inventor name

Average Co-Inventor Count = 2.7

ph-index = 9

Forward Citations = 193(Granted Patents)

Location History:

Glendale, CA (US) (1976)
Portage, MI (US) (1989)
Kalamazoo, MI (US) (1981 - 2005)

Company Filing History:

9 out of 523

Pharmacia & Upjohn Company

Pharmacia Corporation

patents

5. 1 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 1976-2005

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6852731 - Antiviral compounds (2005-02-08),

2. 6624159 - Heterocycle carboxamides as antiviral agents (2003-09-23),

3. 6420360 - Sultam and sultone derived oxazolidinones (2002-07-16),

4. 6348459 - Sultam and sultone derived oxazolidinones (2002-02-19),

5. 6313307 - Phenyloxazolidinones having a C-C bond to 4-8 membered heterocyclic rings (2001-11-06),

6. 6169181 - Compounds useful to treat retroviral infections (2001-01-02),

7. 6166056 - Phenyloxazolidinones having a C-C bond to 4-8 membered heterocyclic rings (2000-12-26),

8. 6043266 - Phenyloxazolidinones having a C--C bond to 4-8 membered heterocyclic (2000-03-28),

9. 5977373 - Thiadiazolyl and oxadiazolyl phenyl oxazolidinone antibacterial agents (1999-11-02),

10. 5852195 - Pyranone compounds useful to treat retroviral infections (1998-12-22),

11. 5686486 - 4-hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl�b!pyran-2-ones (1997-11-11),

12. 5643895 - Phosphonoacetic esters and acids as anti-inflammatories (1997-07-01),

13. 5565441 - Phosphonoacetic esters and acids as anti-inflammatories (1996-10-15),

14. 4873346 - Substituted benzothiazoles, benzimidazoles, and benzoxazoles (1989-10-10),

15. 4450159 - Carbamic acid derivatives as selective immunosuppresive agents (1984-05-22),

Title: David John Anderson: Innovator in Antiviral Compounds

Introduction

David John Anderson is a notable inventor based in Kalamazoo, MI (US). He has made significant contributions to the field of antiviral compounds, holding a total of 18 patents. His work focuses on developing innovative solutions for preventing and treating viral infections.

Latest Patents

Among his latest patents, Anderson has developed compounds that provide effective antiviral properties. One of his inventions includes a compound of formula I, which is designed to prevent or treat herpesvirus infections. This invention also encompasses processes and intermediates useful for preparing such compounds or their pharmaceutically acceptable salts. Another significant patent involves heterocycle carboxamides as antiviral agents, showcasing his commitment to advancing antiviral research.

Career Highlights

Throughout his career, David John Anderson has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Pharmacia & Upjohn Company and The Upjohn Company. His experience in these organizations has contributed to his expertise in developing antiviral agents.

Collaborations

Anderson has collaborated with several professionals in his field, including Steven Ronald Turner and Karen Rene Romines. These collaborations have likely enhanced his research and development efforts in antiviral compounds.

Conclusion

David John Anderson's innovative work in antiviral compounds has positioned him as a key figure in the field. His numerous patents reflect his dedication to improving health outcomes through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com